These compounds may interact with:
Type-1 angiotensin II receptor
Potentially involved in: carcinoma; hypertension; kidney disease; coronary artery disease; diabetes mellitus; heart disease; atherosclerosis; cerebrovascular disease; obesity; urinary tract obstruction; aortic aneurysm; cancer; hyperglycemia; spontaneous abortion; anuria; diabetic retinopathy; patent ductus arteriosus; heart failure; hypertensive disease; hypotension
Disease data sourced from Pharos.